Skip to main content
editorial
. 2021 May 20;42:100905. doi: 10.1016/j.nmni.2021.100905

Table 1.

Comparisons of COVID-19-infected patients by gender

COVID-19 patients Male 187 (47) Female 211 (53) Total (398) p-Value
Age (years) 39.3 ± 17.0 37.9 ± 16.6 38.6 ± 16.8 0.711
Day to symptom (days) 8 ± 8.1 4.8 ± 3.0 5.4 ± 5.0 (101) 0.05
Symptom to diagnosis (days.) 7.4 ± 5.6 7.5 ± 5.6 7.5 ± 5.6 (374) 0.193
Indigenous n (%) 25 (13.4) 29 (13.7) 54 (13.6) 0.913
Imported: Europe 78 (41.7) 88 (41.7) 166 (41.7) 0.439
Imported: America 41 (21.9) 54 (25.6) 95 (23.9)
Imported: Asia 32 (17.1) 36 (17.1) 68 (17)
Imported: Africa 9 (4.8) 3 (1.4) 12 (3)
Imported: Oceania 2 (1.1) 1 (0.5) 3 (0.8)
Test at airport 49 (26.2) 58 (27.5) 107 0.773
Mortality (%) 6 (3.2) 1 (0.5) 7 (1.8) 0.038∗
ICU admission (%) 3 (1.6) 0 (0) 3 (0.8) 0.065
Other diseases
 DM (%) 2 (1.1) 0 (0) 2 (0.5) 0.132
 HTN (%) 3 (1.6) 1 (0.5) 4 (1.0) 0.259
 Uremia (%) 1 (0.5) 0 (0) 1 (0.3) 0.288
Lung infiltration (%) 18 (9.6) 16 (7.6) 34 (8.5) 0.467
Symptoms
 Cough (%) 80 (42.8) 90 (42.3) 170 (42.7) 0.568
 Fever (%) 73 (39.0) 86 (40.8) 159 (39.9) 0.726
 Sore throat (%) 54 (28.9) 53 (25.1) 107 (26.9) 0.399
 Rhinorrhoea (%) 39 (20.1) 60 (28.4) 99 (24.9) 0.083
 Malaise (%) 30 (16.0) 25 (11.8) 55 (13.8) 0.226
 Nasal stuffiness (%) 20 (10.7) 31 (14.7) 51 (12.8) 0.234
 Muscle pain (%) 27 (14.4) 21 (10.0) 48 (12.1) 0.170
 Anosmia (%) 18 (9.6) 29 (13.7) 47 (11.8) 0.204
 Headache (%) 20 (10.7) 14 (6.6) 34 (8.5) 0.148
 Diarrhoea (%) 14 (7.5) 17 (8.1) 31 (7.8) 0.832
 Dysgeusia (%) 10 (5.3) 12 (5.7) 22 (5.5) 0.882
 Chest pain (%) 9 (4.8) 10 (4.7) 19 (4.8) 0.937
 SOB (%) 6 (3.2) 9 (4.3) 15 (3.8) 0.581
 Asymptomatic (%) 10 (5.3) 7 (3.3) 17 (4.3) 0.318

All data are in form of n (%).

DM, diabetes mellitus; SOB, shortness of breath.